The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia

Abstract Background Changes in body composition and systemic inflammation are important characteristics of cancer cachexia. This multi‐centre retrospective study aimed to explore the prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia. M...

Full description

Bibliographic Details
Main Authors: Hai‐Lun Xie, Guo‐Tian Ruan, Lishuang Wei, Qi Zhang, Yi‐Zhong Ge, Meng‐Meng Song, Xi Zhang, Shi‐qi Lin, Xiao‐yue Liu, Xiao‐Wei Zhang, Xiang‐Rui Li, Kang‐Ping Zhang, Chun‐Lei Hu, Ming Yang, Meng Tang, Chun‐Hua Song, Ming‐Hua Cong, Min Weng, Zeng‐Ning Li, Wei Li, Kun‐Hua Wang, Han‐Ping Shi
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Online Access:https://doi.org/10.1002/jcsm.13205
_version_ 1797854136791728128
author Hai‐Lun Xie
Guo‐Tian Ruan
Lishuang Wei
Qi Zhang
Yi‐Zhong Ge
Meng‐Meng Song
Xi Zhang
Shi‐qi Lin
Xiao‐yue Liu
Xiao‐Wei Zhang
Xiang‐Rui Li
Kang‐Ping Zhang
Chun‐Lei Hu
Ming Yang
Meng Tang
Chun‐Hua Song
Ming‐Hua Cong
Min Weng
Zeng‐Ning Li
Wei Li
Kun‐Hua Wang
Han‐Ping Shi
author_facet Hai‐Lun Xie
Guo‐Tian Ruan
Lishuang Wei
Qi Zhang
Yi‐Zhong Ge
Meng‐Meng Song
Xi Zhang
Shi‐qi Lin
Xiao‐yue Liu
Xiao‐Wei Zhang
Xiang‐Rui Li
Kang‐Ping Zhang
Chun‐Lei Hu
Ming Yang
Meng Tang
Chun‐Hua Song
Ming‐Hua Cong
Min Weng
Zeng‐Ning Li
Wei Li
Kun‐Hua Wang
Han‐Ping Shi
author_sort Hai‐Lun Xie
collection DOAJ
description Abstract Background Changes in body composition and systemic inflammation are important characteristics of cancer cachexia. This multi‐centre retrospective study aimed to explore the prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia. Methods The modified advanced lung cancer inflammation index (mALI), which combines body composition and systemic inflammation, was defined as appendicular skeletal muscle index (ASMI) × serum albumin/neutrophil‐lymphocyte ratio. The ASMI was estimated according to a previously validated anthropometric equation. Restricted cubic splines were used to evaluate the relationship between mALI and all‐cause mortality in patients with cancer cachexia. Kaplan–Meier analysis and Cox proportional hazard regression analysis were used to evaluate the prognostic value of mALI in cancer cachexia. A receiver operator characteristic curve was used to compare the effectiveness of mALI and nutritional inflammatory indicators in predicting all‐cause mortality in patients with cancer cachexia. Results A total of 2438 patients with cancer cachexia were enrolled, including 1431 males and 1007 females. The sex‐specific optimal cut‐off values of mALI for males and females were 7.12 and 6.52, respectively. There was a non‐linear relationship between mALI and all‐cause mortality in patients with cancer cachexia. Low mALI was significantly associated with poor nutritional status, high tumour burden, and high inflammation. Patients with low mALI had significantly lower overall survival (OS) than those with high mALI (39.5% vs. 65.5%, P < 0.001). In the male population, OS was significantly lower in the low mALI group than in the high group (34.3% vs. 59.2%, P < 0.001). Similar results were also observed in the female population (46.3% vs. 75.0%, P < 0.001). mALI was an independent prognostic factor for patients with cancer cachexia (hazard ratio [HR] = 0.974, 95% confidence interval [CI] = 0.959–0.990, P = 0.001). For every standard deviation [SD] increase in mALI, the risk of poor prognosis for patients with cancer cachexia was reduced by 2.9% (HR = 0.971, 95%CI = 0.943–0.964, P < 0.001) in males and 8.9% (HR = 0.911, 95%CI = 0.893–0.930, P < 0.001) in females. mALI is an effective complement to the traditional Tumour, Lymph Nodes, Metastasis (TNM) staging system for prognosis evaluation and a promising nutritional inflammatory indicator with a better prognostic effect than the most commonly used clinical nutritional inflammatory indicators. Conclusions Low mALI is associated with poor survival in both male and female patients with cancer cachexia and is a practical and valuable prognostic assessment tool.
first_indexed 2024-04-09T20:02:00Z
format Article
id doaj.art-66ffc3514e004322969e2cdc50205858
institution Directory Open Access Journal
issn 2190-5991
2190-6009
language English
last_indexed 2024-04-09T20:02:00Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series Journal of Cachexia, Sarcopenia and Muscle
spelling doaj.art-66ffc3514e004322969e2cdc502058582023-04-03T02:38:50ZengWileyJournal of Cachexia, Sarcopenia and Muscle2190-59912190-60092023-04-0114287989010.1002/jcsm.13205The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexiaHai‐Lun Xie0Guo‐Tian Ruan1Lishuang Wei2Qi Zhang3Yi‐Zhong Ge4Meng‐Meng Song5Xi Zhang6Shi‐qi Lin7Xiao‐yue Liu8Xiao‐Wei Zhang9Xiang‐Rui Li10Kang‐Ping Zhang11Chun‐Lei Hu12Ming Yang13Meng Tang14Chun‐Hua Song15Ming‐Hua Cong16Min Weng17Zeng‐Ning Li18Wei Li19Kun‐Hua Wang20Han‐Ping Shi21Department of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Geriatric Respiratory Disease Ward, the First Affiliated Hospital Guangxi Medical University Nanning ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaBeijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition Beijing ChinaDepartment of Epidemiology, College of Public Health Zhengzhou University Zhenzhou ChinaGeneral Department, Cancer Hospital Chinese Academy of Medical Sciences Beijing ChinaDepartment of Clinical Nutrition The First Affiliated Hospital of Kunming Medical University Kunming ChinaDepartment of Clinical Nutrition The First Affiliated Hospital of Hebei Medical University Shijiazhuang ChinaCancer Center The First Hospital of Jilin University Changchun ChinaDepartment of Surgery The First Affiliated Hospital of Kunming Medical University Kunming ChinaDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital Capital Medical University Beijing ChinaAbstract Background Changes in body composition and systemic inflammation are important characteristics of cancer cachexia. This multi‐centre retrospective study aimed to explore the prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia. Methods The modified advanced lung cancer inflammation index (mALI), which combines body composition and systemic inflammation, was defined as appendicular skeletal muscle index (ASMI) × serum albumin/neutrophil‐lymphocyte ratio. The ASMI was estimated according to a previously validated anthropometric equation. Restricted cubic splines were used to evaluate the relationship between mALI and all‐cause mortality in patients with cancer cachexia. Kaplan–Meier analysis and Cox proportional hazard regression analysis were used to evaluate the prognostic value of mALI in cancer cachexia. A receiver operator characteristic curve was used to compare the effectiveness of mALI and nutritional inflammatory indicators in predicting all‐cause mortality in patients with cancer cachexia. Results A total of 2438 patients with cancer cachexia were enrolled, including 1431 males and 1007 females. The sex‐specific optimal cut‐off values of mALI for males and females were 7.12 and 6.52, respectively. There was a non‐linear relationship between mALI and all‐cause mortality in patients with cancer cachexia. Low mALI was significantly associated with poor nutritional status, high tumour burden, and high inflammation. Patients with low mALI had significantly lower overall survival (OS) than those with high mALI (39.5% vs. 65.5%, P < 0.001). In the male population, OS was significantly lower in the low mALI group than in the high group (34.3% vs. 59.2%, P < 0.001). Similar results were also observed in the female population (46.3% vs. 75.0%, P < 0.001). mALI was an independent prognostic factor for patients with cancer cachexia (hazard ratio [HR] = 0.974, 95% confidence interval [CI] = 0.959–0.990, P = 0.001). For every standard deviation [SD] increase in mALI, the risk of poor prognosis for patients with cancer cachexia was reduced by 2.9% (HR = 0.971, 95%CI = 0.943–0.964, P < 0.001) in males and 8.9% (HR = 0.911, 95%CI = 0.893–0.930, P < 0.001) in females. mALI is an effective complement to the traditional Tumour, Lymph Nodes, Metastasis (TNM) staging system for prognosis evaluation and a promising nutritional inflammatory indicator with a better prognostic effect than the most commonly used clinical nutritional inflammatory indicators. Conclusions Low mALI is associated with poor survival in both male and female patients with cancer cachexia and is a practical and valuable prognostic assessment tool.https://doi.org/10.1002/jcsm.13205Body compositionSystemic inflammationCancer cachexiaPrognostic
spellingShingle Hai‐Lun Xie
Guo‐Tian Ruan
Lishuang Wei
Qi Zhang
Yi‐Zhong Ge
Meng‐Meng Song
Xi Zhang
Shi‐qi Lin
Xiao‐yue Liu
Xiao‐Wei Zhang
Xiang‐Rui Li
Kang‐Ping Zhang
Chun‐Lei Hu
Ming Yang
Meng Tang
Chun‐Hua Song
Ming‐Hua Cong
Min Weng
Zeng‐Ning Li
Wei Li
Kun‐Hua Wang
Han‐Ping Shi
The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
Journal of Cachexia, Sarcopenia and Muscle
Body composition
Systemic inflammation
Cancer cachexia
Prognostic
title The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
title_full The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
title_fullStr The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
title_full_unstemmed The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
title_short The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
title_sort prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
topic Body composition
Systemic inflammation
Cancer cachexia
Prognostic
url https://doi.org/10.1002/jcsm.13205
work_keys_str_mv AT hailunxie theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT guotianruan theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT lishuangwei theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT qizhang theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT yizhongge theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT mengmengsong theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT xizhang theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT shiqilin theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT xiaoyueliu theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT xiaoweizhang theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT xiangruili theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT kangpingzhang theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT chunleihu theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT mingyang theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT mengtang theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT chunhuasong theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT minghuacong theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT minweng theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT zengningli theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT weili theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT kunhuawang theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT hanpingshi theprognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT hailunxie prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT guotianruan prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT lishuangwei prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT qizhang prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT yizhongge prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT mengmengsong prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT xizhang prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT shiqilin prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT xiaoyueliu prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT xiaoweizhang prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT xiangruili prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT kangpingzhang prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT chunleihu prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT mingyang prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT mengtang prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT chunhuasong prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT minghuacong prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT minweng prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT zengningli prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT weili prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT kunhuawang prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia
AT hanpingshi prognosticvalueofthecombinationofbodycompositionandsystemicinflammationinpatientswithcancercachexia